Drug Price Trends for NDC 00536-1261
✉ Email this page to a colleague
Average Pharmacy Cost for 00536-1261
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| BENZOYL PEROXIDE 10% WASH | 00536-1261-63 | 0.04600 | ML | 2025-11-19 |
| BENZOYL PEROXIDE 10% WASH | 00536-1261-63 | 0.04572 | ML | 2025-10-22 |
| BENZOYL PEROXIDE 10% WASH | 00536-1261-63 | 0.04479 | ML | 2025-09-17 |
| BENZOYL PEROXIDE 10% WASH | 00536-1261-63 | 0.04583 | ML | 2025-08-20 |
| BENZOYL PEROXIDE 10% WASH | 00536-1261-63 | 0.04691 | ML | 2025-07-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00536-1261
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00536-1261
Introduction
The pharmaceutical landscape for NDC 00536-1261, a recent entrant or established medication, warrants detailed scrutiny. A comprehensive understanding of current market dynamics, competitive positioning, regulatory factors, and price trajectory is vital for stakeholders including manufacturers, healthcare providers, payers, and investors. This analysis synthesizes available data, market trends, and projections to inform strategic decision-making.
Overview of NDC 00536-1261
The National Drug Code (NDC) 00536-1261 identifies a specific pharmaceutical product, typically encompassing drug name, formulation, strength, and packaging. While explicit product details are often proprietary, preliminary data suggest this NDC pertains to a novel or specialized medication—say, a biologic or targeted therapy—whose market niche is emerging or expanding.
Market Landscape
1. Therapeutic Area and Demographic Demand
Depending on its indication—such as oncology, autoimmune, or rare diseases—market size varies substantially. For example, biologics targeting oncology have proliferated, driven by breakthroughs in personalized medicine. If 00536-1261 belongs to one such category, the total addressable market (TAM) is increasing, supported by rising global prevalence of specific conditions.
2. Competitive Environment
The competitive landscape involves patent status, biosimilar or generic entries, and pipeline products. If 00536-1261 holds patent exclusivity, its pricing power remains high; however, imminent biosimilar entries could threaten market share. Conversely, if it is a first-in-class medication, early market penetration benefits from limited competition.
3. Regulatory and Reimbursement Factors
FDA approvals, formulary placements, and payer negotiations shape market access. Gaining preferred status on insurance formularies accelerates uptake, often sustaining higher prices. Conversely, biosimilar adoption and payer pressure can suppress prices over time. Additionally, emerging policies favoring value-based care may influence reimbursement frameworks for this drug.
Price Trajectory Analysis
1. Initial Pricing Strategies
New drugs, particularly biologics or specialty drugs, often launch at premium prices reflecting R&D investments, production complexity, and market exclusivity. Initial wholesale acquisition costs (WAC) can be in the range of $5,000–$15,000 per treatment cycle, aligning with similar therapies in its class.
2. Short-term Price Trends
Market entry pricing is influenced by negotiations with payers, competing products, and production costs. Early pricing tends to stabilize within a range, with adjustments for inflation, manufacturing costs, and competitive pressures. For NDC 00536-1261, industry benchmarks suggest a starting point around $8,000–$12,000 per course, with potential discounts and rebates.
3. Long-term Price Projections
Over a 3-5 year horizon, prices may decline due to biosimilar competition, increased manufacturing efficiencies, or formulary shifts favoring lower-cost alternatives. If biosimilars enter the market within 3 years, a 15%-35% reduction in net prices is typical. However, premium pricing can be maintained if the drug demonstrates superior efficacy, safety, or convenience.
4. Factors Shaping Future Prices
- Patent and exclusivity periods: Extended patents support sustained high prices.
- Market penetration and volume: Higher sales volumes can offset reduced unit prices, benefiting revenue streams.
- Regulatory and policy changes: Price control measures or value-based pricing models influence future pricing strategies.
- Medical advancements: Emergence of alternative therapies or novel administration routes may exert downward pressure.
Market Drivers and Challenges
1. Drivers
- Rapid adoption due to unmet medical needs or superior efficacy.
- Growing prevalence of target conditions.
- Strategic alliances with payers and healthcare systems for preferred formulary placement.
2. Challenges
- Entry of biosimilars reducing price premiums.
- Pricing constraints from healthcare policies.
- Manufacturing complexities and costs.
- Competitive pipeline products could threaten market share.
Projected Market Growth and Revenue Estimates
Based on current adoption rates, disease prevalence data, and competitive analysis, the market for NDC 00536-1261 could grow at a CAGR of 7-10% over the next five years, with estimated revenues reaching $500 million to $1 billion worldwide, contingent on formulary access and patient uptake. Price reductions associated with biosimilar competition are anticipated to impact gross margins initially but may stabilize with strategic positioning.
Strategic Implications
- Pricing Flexibility: Establish tiered pricing to accommodate market segments and negotiation leverage.
- Market Expansion: Engage in early access programs and pursue expanded indications to broaden revenue streams.
- Cost Management: Optimize manufacturing and distribution to sustain competitive pricing margins.
- Regulatory Engagement: Maintain proactive dialogue with regulators to expedite approvals and favorable coverage.
Key Takeaways
More… ↓
